Lightolon Eye Drops 0.2% (Olopatadine Hydrochloride), Lightolon Eye Drops 0.2% (Olopatadine Hydrochloride) (Single Use)
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Light PharmTech Co., Ltd.
MFDS item code 201504234 · Approved 2015.06.30 · Insurance code 690300241,690301421
Relief of allergic conjunctivitis symptoms
This medication helps relieve symptoms such as itching, redness, and tearing of the eyes caused by allergic conjunctivitis. It reduces inflammation around the eyes and improves uncomfortable symptoms, thereby decreasing the discomfort experienced in daily life. It effectively treats symptoms by quickly alleviating discomfort and controlling allergic reactions.
1 drop per dose, instilled once a day.
This medication should not be used by patients with an allergic reaction to the active ingredient or any component. While using this medication, neurological symptoms such as headache, taste disturbance, and dizziness may occur. Rare symptoms such as punctate keratitis, keratitis, eye pain, dryness, redness, and itching may also occur, and there may be experiences of glare or blurred vision. Nasal dryness or rhinitis symptoms can occur, and symptoms like dry mouth or dermatitis have also been reported rarely. Patients may feel fatigued. This medication should not be used to relieve irritation associated with contact lens wear, and if soft contact lenses are worn, they can only be put back in at least 15 minutes after instillation. While this medication is a non-sedating antihistamine, temporary blurring of vision can occur after instillation, so it is necessary to wait until vision clears before driving or operating machinery. During pregnancy, the effects on the fetus should be carefully considered while using this medication, and caution is required during breastfeeding as it may also affect the baby. It is safe to use in children aged 3 years and older, and elderly patients show similar safety and efficacy as regular adults. This medication should only be used locally in the eyes and should not be used for intravenous injection or oral administration. Care should be taken not to allow the tip of the container to touch the eye, and the cap should be securely closed after use to prevent contamination. If used with other eye drops, a minimum interval of 5 minutes should be observed, and it is preferable to administer ointments last. In cases of excessive use of this medication, patients should be closely monitored and receive appropriate treatment. For single-use products, they should only be used once after opening, and the first drop should be discarded to remove any foreign substances from inside the container. This medication contains phosphates, so caution is needed for patients with severe corneal damage due to the rare occurrence of corneal calcification.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container that can block light. Multi-dose containers should be stored at cool temperatures between 4 degrees and 25 degrees, and single-dose containers should be stored at temperatures between 2 degrees and 25 degrees. Storing in this way will help maintain the efficacy of the medication for a long time.
[With Preservative] A colorless to pale yellow liquid in an opaque white plastic container, Eye Drops, [Without Preservative] A colorless to pale yellow liquid in a colorless transparent plastic container, Eye Drops
With Preservative - 3 milliliters/bottle, Without Preservative - 30 tubes/box [0.35 mL/tube]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Light PharmTech Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.